Clinigen facilitated the licence transfer of a biological oncology product, enabling a successful acquisition and seamless integration within a complex regulatory landscape. Our comprehensive approach included due diligence, risk management, regulatory compliance, and operational transition. This ensured ongoing compliance, market continuity, and operational readiness post-acquisition.

Read this case study to learn how Clinigen facilitated a licence transfer, enabling a successful acquisition, and seamless integration of a biological oncology product within a complex regulatory landscape.